Saturday 17 October 2026
Export PHG’s income statement to Excel — free account
Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.
25.74
0.25
+0.98%
Follow PHG
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | — | 7 |
| 5.98% | 8.02% | 8.63% | 10.20% | ||
| 2.44% | 3.25% | 3.67% | 4.21% | ||
ROIC |
4.64% | 5.91% | 5.91% | 6.69% | |
Return on Tangible Assets |
14.68% | 19.29% | 20.90% | 27.07% | |
Average Days of Receivables |
74.25 | 73.47 | 69.14 | 74.19 | |
Free Cash Flow per Share |
(1.30) | 0.61 | 1.85 | 1.94 | |
Free Cash Flow |
(1,234.96) | 580.41 | 1,763.60 | 1,849.65 | |
Capital Expenditures |
(890.67) | (745.59) | (765.35) | (751.93) | |
| Other line items | |||||
Cash ROIC |
(5.33%) | 2.47% | 7.18% | 8.10% | |
Accounts Receivable Turnover |
4.71 | 4.86 | 5.42 | 5.17 | |
Accounts Payable Turnover |
5.48 | 5.30 | 5.26 | 3.70 | |
Inventory Turnover |
2.52 | 3.10 | 3.13 | 3.00 | |
Average Days of Payables |
70.19 | 71.95 | 75.92 | 79.35 | |
Days of Inventory on Hand |
133.57 | 107.16 | 118.66 | 122.68 | |
Tax Rate |
(0.29) | (0.24) | (0.24) | (0.25) | |
Research and Development Expense of Revenue |
9.95% | 9.53% | 9.31% | 9.77% | |
Selling, General and Administrative Expense of Revenue |
28.54% | 27.87% | 27.87% | 27.66% | |
Share Based Compensation of Revenue |
0.89% | 0.79% | 0.71% | 0.80% | |
Interest Coverage |
3.59 | 4.12 | 4.30 | 4.70 | |
Operating CF/Net income |
(0.45) | 1.31 | 2.28 | 2.03 | |
Depreciation/Fixed assets |
0.65 | 0.51 | 0.51 | 0.56 | |
Capex/Depreciation |
(0.53) | (0.59) | (0.59) | (0.53) | |
Revenue per Share |
20.07 | 21.28 | 21.47 | 21.53 | |
Operating CF per Share |
(0.36) | 1.40 | 2.66 | 2.72 | |
Capex per Share |
(0.94) | (0.79) | (0.80) | (0.79) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 |
Columns are period end dates